AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.

Meta’s Automating 90% of Risk Assessments, ‘Creating Higher Risks’ Says Former Exec Your email has been sent Meta is transitioning the majority of its internal safety and privacy reviews to ...

HC Legionella has the knowledge, skill, and competence to undertake a bespoke legionella risk assessment for your site; we work in line with the LCA service standards, BS 8580-1 and BS 8680 guidance, ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image ...

Current and former Meta employees fear the new automation push comes at the cost of allowing AI to make tricky determinations about how Meta's apps could lead to real world harm.

Kyle, who travels nationwide to undertake legionella risk assessments, said he really enjoys the variety of the role, which also includes site schematics to accompany the risk assessments.